 GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 04, 2021 GLOBE NEWSWIRE -- Applied Genetic Technologies Corporation Nasdaq: AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus AAV-based gene therapies for the treatment of rare diseases, today announced that it will report financial results for the fiscal quarter ended December 31, 2020 before the market opens on Thursday, February 11, 2021. AGTC management will host a conference call beginning at 8:00 AM Eastern Time on the same date to review results and provide a corporate update. 